Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections

Research area

Devices & Dosimetry

Wavelengths, power, dose and how well real devices match their claims.

2,411 studies · Last updated November 16, 2026

2017Studies per year2026 so far
Devices & Dosimetry

Laser therapies as the adjunctive treatment of medication-related osteonecrosis of the jaw: Evidence synthesis and clinical recommendations. Official recommendations of the World Federation for Laser Dentistry (WFLD) and the Polish Society for Laser Dentistry (PTSL)

Laser-based therapies may provide beneficial adjunctive effects in MRONJ management, particularly within multimodal treatment strategies. However, the strength of these conclusions is limited due to substantial heterogeneity in study design, laser protocols and outcome reporting.

Review · May 14, 2026 · Grzech-Leśniak K et al.

Devices & Dosimetry

Lasers for Melasma

Maintenance treatment is crucial to prevent recurrence. Despite advancements, laser treatments must be approached cautiously due to risks like postinflammatory hyperpigmentation, especially in darker skin types.

Review · May 13, 2026 · Campos V et al.

Devices & Dosimetry

Standardized Photobiomodulation Dosimetry Targeting the Base of Calvarial Critical-Sized Defects for Bone Regeneration: A Preclinical RCT Comparing Flattop vs. Gaussian Beam Profiles, with or Without Bio-Oss®

PBM enhanced progenitor activation, osteoblast differentiation, angiogenesis, matrix deposition, and late-stage remodeling, demonstrating a synergistic effect with the scaffold, whereas Bio-Oss® alone or defect alone showed limited early regenerative potential.

Study · March 4, 2026 · Hanna R et al.

Devices & Dosimetry

Xanthelasma-Like Reaction Following Poly-L-Lactic Acid Intradermal Injection Managed With Fractional Non-Ablative Lasers and Stem Cell-Derived Conditioned Media: A Case Report

This case highlights a rare xanthelasma-like reaction following polymer-based collagen stimulator injection and demonstrates that a staged, non-ablative fractional laser approach with adjunctive stem cell-derived conditioned media may be an effective and minimally invasive management option.

Study · February 1, 2026 · Wibisono O et al.

Devices & Dosimetry

The effect of different time intervals of diode laser irradiation on the in Ovo chick embryo yolk sac membrane for angiogenic differentiation - an in Ovo pilot experimental study

Diode laser irradiation enhances angiogenesis, with 45 s being the optimal exposure time for angiogenic differentiation. These findings suggest that highlight LLLT may accelerate healing and tissue repair, warranting further research for clinical applications.

Study · December 16, 2025 · Lawate S et al.

Devices & Dosimetry

Efficacy of intense pulsed light therapy combined with eyelid margin cleaning using a deep cleaning device in the treatment of meibomian gland dysfunction: a randomized controlled trial

IPL therapy combined with deep eyelid margin cleaning alleviates meibomian gland orifice obstruction and improves tear film stability. This study establishes a new treatment paradigm, with a shift from passive thermal modulation to active ductal remodeling.

Trial · December 12, 2025 · Tang Y et al.

Devices & Dosimetry

Type of study: original study

DWPBM demonstrated superior clinical outcomes, enhanced LBF and reduced periodontal pathogens, suggesting its role as a valuable therapeutic modality.

Trial · November 10, 2025 · Chittabathina P et al.

Devices & Dosimetry

Fractional non ablative 675 nm diode laser versus low fluence high frequency Q- switched 1064 nm nd: YAG laser in the treatment of melasma: a comparative split face trial

Adverse events were mild and transient. Fractional non-ablative 675 nm diode laser is more effective and equally safe compared to Q-switched 1064 nm Nd:YAG laser in treating facial melasma, offering a promising modality for patients with recalcitrant hyperpigmentation.

Trial · October 15, 2025 · Bassiony HM et al.